Literature DB >> 27832528

Fluorescence Reporter-Based Genome-Wide RNA Interference Screening to Identify Alternative Splicing Regulators.

Ashish Misra1, Michael R Green2.   

Abstract

Alternative splicing is a regulated process that leads to inclusion or exclusion of particular exons in a pre-mRNA transcript, resulting in multiple protein isoforms being encoded by a single gene. With more than 90 % of human genes known to undergo alternative splicing, it represents a major source for biological diversity inside cells. Although in vitro splicing assays have revealed insights into the mechanisms regulating individual alternative splicing events, our global understanding of alternative splicing regulation is still evolving. In recent years, genome-wide RNA interference (RNAi) screening has transformed biological research by enabling genome-scale loss-of-function screens in cultured cells and model organisms. In addition to resulting in the identification of new cellular pathways and potential drug targets, these screens have also uncovered many previously unknown mechanisms regulating alternative splicing. Here, we describe a method for the identification of alternative splicing regulators using genome-wide RNAi screening, as well as assays for further validation of the identified candidates. With modifications, this method can also be adapted to study the splicing regulation of pre-mRNAs that contain two or more splice isoforms.

Entities:  

Keywords:  Alternative splicing; Flow cytometry; Genome-wide; Pre-mRNA; RBFOX2; RNA interference

Mesh:

Substances:

Year:  2017        PMID: 27832528      PMCID: PMC5508546          DOI: 10.1007/978-1-4939-6518-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  The art and design of genetic screens: mammalian culture cells.

Authors:  Stefan Grimm
Journal:  Nat Rev Genet       Date:  2004-03       Impact factor: 53.242

Review 2.  RNAi screening: new approaches, understandings, and organisms.

Authors:  Stephanie E Mohr; Norbert Perrimon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-09-22       Impact factor: 9.957

Review 3.  shRNA libraries and their use in cancer genetics.

Authors:  René Bernards; Thijn R Brummelkamp; Roderick L Beijersbergen
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

Review 4.  RNAi screening comes of age: improved techniques and complementary approaches.

Authors:  Stephanie E Mohr; Jennifer A Smith; Caroline E Shamu; Ralph A Neumüller; Norbert Perrimon
Journal:  Nat Rev Mol Cell Biol       Date:  2014-09       Impact factor: 94.444

5.  An alternative splicing network links cell-cycle control to apoptosis.

Authors:  Michael J Moore; Qingqing Wang; Caleb J Kennedy; Pamela A Silver
Journal:  Cell       Date:  2010-08-12       Impact factor: 41.582

Review 6.  Genome-scale loss-of-function screening with a lentiviral RNAi library.

Authors:  David E Root; Nir Hacohen; William C Hahn; Eric S Lander; David M Sabatini
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

7.  Systematic identification and analysis of exonic splicing silencers.

Authors:  Zefeng Wang; Michael E Rolish; Gene Yeo; Vivian Tung; Matthew Mawson; Christopher B Burge
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

Review 8.  Genomic screening with RNAi: results and challenges.

Authors:  Stephanie Mohr; Chris Bakal; Norbert Perrimon
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

9.  Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors.

Authors:  Ashish Misra; Jianhong Ou; Lihua J Zhu; Michael R Green
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

Review 10.  Knocking down barriers: advances in siRNA delivery.

Authors:  Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

View more
  1 in total

Review 1.  Discovering antiviral restriction factors and pathways using genetic screens.

Authors:  Chloe E Jones; Wenfang S Tan; Finn Grey; David J Hughes
Journal:  J Gen Virol       Date:  2021-05       Impact factor: 3.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.